131 related articles for article (PubMed ID: 6126170)
1. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
[TBL] [Abstract][Full Text] [Related]
2. Effect of gamma-vinyl GABA in tardive dyskinesia.
Korsgaard S; Casey DE; Gerlach J
Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
[TBL] [Abstract][Full Text] [Related]
3. gamma-Acetylenic GABA in tardive dyskinesia.
Casey DE; Gerlach J; Magelund G; Christensen TR
Arch Gen Psychiatry; 1980 Dec; 37(12):1376-9. PubMed ID: 6108751
[TBL] [Abstract][Full Text] [Related]
4. GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.
Andersson U; Häggström JE
Psychopharmacology (Berl); 1988; 94(3):298-301. PubMed ID: 2895937
[TBL] [Abstract][Full Text] [Related]
5. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
Soares KV; McGrath JJ; Deeks JJ
Cochrane Database Syst Rev; 2001; (2):CD000203. PubMed ID: 11405955
[TBL] [Abstract][Full Text] [Related]
6. Sulpiride in tardive dyskinesia.
Casey DE; Gerlach J; Simmelsgaard H
Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
[TBL] [Abstract][Full Text] [Related]
7. High-dose destyrosine-gamma-endorphin in tardive dyskinesia.
Korsgaard S; Casey DE; Gerlach J
Psychopharmacology (Berl); 1982; 78(3):285-6. PubMed ID: 6130557
[TBL] [Abstract][Full Text] [Related]
8. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
Soares KV; McGrath JJ; Deeks JJ
Cochrane Database Syst Rev; 2000; (2):CD000203. PubMed ID: 10796320
[TBL] [Abstract][Full Text] [Related]
9. Fluperlapine in tardive dyskinesia and parkinsonism.
Korsgaard S; Noring U; Gerlach J
Psychopharmacology (Berl); 1984; 84(1):76-9. PubMed ID: 6149595
[TBL] [Abstract][Full Text] [Related]
10. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
Morselli PL; Fournier V; Bossi L; Musch B
Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656
[TBL] [Abstract][Full Text] [Related]
11. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
[TBL] [Abstract][Full Text] [Related]
12. Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism.
Noring U; Povlsen UJ; Casey DE; Gerlach J
Psychopharmacology (Berl); 1984; 84(4):569-71. PubMed ID: 6152058
[TBL] [Abstract][Full Text] [Related]
13. Improvement in tardive dyskinesia after muscimol therapy.
Tamminga CA; Crayton JW; Chase TN
Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
Richardson MA; Haugland G; Craig TJ
Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
Richardson MA; Bevans ML; Read LL; Chao HM; Clelland JD; Suckow RF; Maher TJ; Citrome L
Am J Psychiatry; 2003 Jun; 160(6):1117-24. PubMed ID: 12777270
[TBL] [Abstract][Full Text] [Related]
16. Effect of des-tyrosine-gamma-endorphin in tardive dyskinesia.
Casey DE; Korsgaard S; Gerlach J; Jørgensen A; Simmelsgaard H
Arch Gen Psychiatry; 1981 Feb; 38(2):158-60. PubMed ID: 7011248
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
Ziegler M; Fournier V; Bathien N; Morselli PL; Rondot P
Clin Neuropharmacol; 1987 Jun; 10(3):238-46. PubMed ID: 2900682
[TBL] [Abstract][Full Text] [Related]
18. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
[TBL] [Abstract][Full Text] [Related]
19. The analgesic effect of the GABA-agonist THIP in patients with chronic pain of malignant origin. A phase-1-2 study.
Kjaer M; Nielsen H
Br J Clin Pharmacol; 1983 Nov; 16(5):477-85. PubMed ID: 6639833
[TBL] [Abstract][Full Text] [Related]
20. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
